A systematic review provides disappointingly little guidance on the selection of nonpharmacologic therapies for children with ADHD.
Effective nonpharmacologic approaches to treat childhood and adolescent ADHD would be welcomed, particularly to avoid some of the adverse side effects of psychostimulants, the mainstay of treatment. Although nonpharmacologic therapies are available, evaluation of their safety and effectiveness is sparse.
In the current update to a 2011 systematic review on ADHD therapies in preschoolers (NEJM JW Psychiatry Jun 2013 and Pediatrics 2013; 131:e1584), researchers identified and evaluated 54 studies assessing the effectiveness of nonpharmacologic therapies for ADHD in children and adolescents (aged <17 years) published between 2009 and 2016. All studies included comparators of other nonpharmacologic therapies, FDA-approved pharmacologic therapies…
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)